Discover the full record of transactions filed by Coleman Mark, Director. Insider active across 1 companies, notably Axsome Therapeutics, Inc.. Aggregated, 5 reports have been logged. Total volume traded: €73k. The latest transaction was filed on 15 March 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Mark Coleman is a Board Member at Axsome Therapeutics, Inc., a biopharmaceutical company. As a board member, he participates in the strategy and management of the company. His expertise in the pharmaceutical sector is an asset for Axsome.